Elon Musk lately expressed his views on drug use and its potential advantages on X, sparking a flurry of reactions.
What Occurred: In a publish on X on Saturday, Musk responded to a tweet about “darkish conspiracies” surrounding OpenAI, an organization he helped construct.
He humorously lamented not getting ice cream throughout his time there.
The dialog took a flip when Musk responded to a different person on X, stating, “If cocaine really helped with long-term productiveness, I might undoubtedly take it!”
He additional added, “For any given drug, should you can full the sentence ‘[blank] made me a greater particular person’, then I believe it needs to be authorized.”
Additionally Learn: Is Elon Musk Turning into Extra Like Donald Trump? One Report Suggests So
Musk’s feedback come amid latest allegations that he’s fostering a drug-friendly tradition inside his firms, Tesla Inc. and SpaceX.
Why It Issues: Musk’s views on drug use have been a subject of controversy prior to now. A Bloomberg report from earlier this month highlighted a lawsuit towards Musk for allegedly utilizing medication and posting underneath the affect. Earlier in February, Musk’s alleged normalization of drug use amongst his enterprise associates got here into the image, which led to a tradition the place declining to make use of medication might end in fears of dropping wealth and social standing.
Issues about Musk’s drug use have been linked to his unorthodox habits, inflicting unease amongst his shut associates.
Given this context, Musk’s latest feedback on X have reignited the controversy round his stance on drug use and its implications for his firms and their tradition.
Now Learn: Elon Musk Voices Opposition To Potential TikTok Ban: ‘It Is Not What America Stands For’
This content material was partially produced with the assistance of Benzinga Neuro and was reviewed and revealed by Benzinga editors.
Photograph: Shutterstock
Market Information and Information delivered to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
